ASO Stock News & Sentiment

ASO stock is set to benefit from rewarding shareholders by hiking quarterly dividend payments. Know more about the recent hike.

WASHINGTON , Feb. 24, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article entitled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S" in Molecular Therapy Nucleic Acids1, a Cell Press partner journal, that describes the development of a novel antisense oligonucleotide (ASO) therapeutic, VCA-894A, for a patient with a rare variant in the IGHMBP2 gene causing Charcot-Marie-Tooth disease Type 2S (CMT2S). In 1886, Jean-Martin Charcot, Pierre Marie, and Henry Tooth independently described this hereditary motor and sensory neuropathy in their patients, paving the way for Charcot-Marie-Tooth (CMT) disease research.2,3 It was not until 1968 that a distinction was made in CMT disease, creating the classification of CMT1 and CMT2.4 Since then, CMT disease (OMIM: 616155) has been used as a model disease to describe genetic heterogeneity.5 However, the high genetic and allelic heterogeneity of CMT disease poses a challenge for both diagnosis and treatment.

Academy Sports and Outdoors is expanding aggressively, planning to open 160-180 new stores over five years, leveraging favorable demographics in high-growth markets. Despite 11 quarters of negative same-store sales, ASO has consistently generated positive free cash flow, highlighting operational efficiency. TTM FCF yield is 11%. For fiscal year 2025, I expect ASO to deliver same-store sales growth in the low-single digits. This coupled with new store openings should push the overall sales growth to mid-single digits.

Academy Sports and Outdoors is a small-cap retailer with a wide economic moat and excellent value offering to customers. The company operates 290 stores across 18 states, offering a broad range of sports and outdoor products which outpaces the comparative offerings of rivals. Despite a tough Q3, Academy maintains strong financials with impressive margins, robust cash flow, and a conservative balance sheet.

We also respond to questions from listeners regarding diversification within the S&P 500.

In summary, 2024 was a good year for getting "average" returns in the stock market. This includes companies like Crocs (NASDAQ: CROX), Academy Sports and Outdoors (NASDAQ: ASO), and Universal Display (NASDAQ: OLED). Crocs is considered a low-cost stock, with a price-to-earnings ratio of only 8, while many other stocks have ratios above 20.

With just three weeks left in the year (as of this writing), the S&P 500 is up nearly 27% in 2024. To illustrate how great this gain is, if someone invested $10,000 and gained 27% annually, they'd have over $100,000 in just 10 years.

Academy Sports & Outdoors faces challenges with profitability and sales growth, despite boasting industry-leading metrics and expansion potential. Q3 2024 earnings show declines in net sales, net income, and EPS, with a negative trend persisting year-to-date. The company has improved its balance sheet, reduced leverage, and initiated significant share repurchase programs, indicating financial stability.

Academy Sports and Outdoors' third-quarter fiscal 2024 results are hurt by challenges in October, which proves to be a tough month for the company.